Table 3.

Chimerism in different cell subsets in the recipients of 2 major histocompatibility complex-mismatched allogeneic T-cell-depleted bone marrow cells

CD4+ T cells*CD8+ T cells*B cells*Myeloid cells*NKsDCs
C57BL/6-derived 26 ± 15 32 ± 18 17 ± 16 11 ± 1 41 ± 30 37 ± 29 
SJL/J-derived 40 ± 35 40 ± 34 79 ± 14 79 ± 7 58 ± 30 56 ± 30 
BALB/c-derived 33 ± 20 29 ± 18 3 ± 5 8 ± 6 0 ± 0 4 ± 3 
CD4+ T cells*CD8+ T cells*B cells*Myeloid cells*NKsDCs
C57BL/6-derived 26 ± 15 32 ± 18 17 ± 16 11 ± 1 41 ± 30 37 ± 29 
SJL/J-derived 40 ± 35 40 ± 34 79 ± 14 79 ± 7 58 ± 30 56 ± 30 
BALB/c-derived 33 ± 20 29 ± 18 3 ± 5 8 ± 6 0 ± 0 4 ± 3 

Data are given as the percentage of chimeric cells.

NKs indicate natural killer cells; DCs, dendritic cells.

*

Results from peripheral blood harvested 6 weeks after stem cell transplantation (C57BL/6 + SJL/J → BALB/c); n = 8. Similar experiments were repeated twice.

Results from spleen cells harvested 120 days after stem cell transplantation; n = 6.

Close Modal

or Create an Account

Close Modal
Close Modal